Work

Characterization of NCGC1360 and NCGC1366 as Highly-Selective D2 Dopamine Receptor Antagonists and Lead Candidates for the Treatment of Neuropsychiatric Disorders

Year: 2024

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.475.903110

Authors: Ashley N. Nilson, John N. Hanson, Tej Poudel, Andres E. Dulcey, Ramona M. Rodriguiz, Kuo Hao Lee, R. Benjamin Free, Raul R. Calvo, Lei Shi, William C. Wetsel, Juan J. Marugan, David R. Sibley

Institutions: National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences, Duke Medical Center, National Institute on Drug Abuse

Language: English

Topic: Receptor Mechanisms and Signaling

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396849838

FWCI:

Cites:

Cited by:

Related to: 10